TILT Biotherapeutics

is a Finland-based clinical-stage biotechnology company that develops oncolytic immunotherapies for the treatment of cancer...
Read more
TILT Biotherapeutics Founder & CEO: Akseli Hemminki

Founder & CEO

Akseli Hemminki

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$63.6M

TILT Biotherapeutics Competitors

1Sorrento
2Tessa
3Tmunity
4Adaptive Biotechnologies
5Abvitro
6Juno Therapeutics
7iRepertoire
8Anaeropharma Science
9Autolus
10Jounce

Trending Companies